Mind Medicine (MindMed) Inc. (MMED.NE)

14.90 +1.29 (+9.48%) At close: 03:55PM EDT

Mind Medicine (MindMed) Inc.

One World Trade Center
Suite 8500
New York, NY 10007
United States
212-220-6633
https://www.mindmed.co

Sector(s): 
Industry: 
Full Time Employees: 57

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert Barrow	CEO & Director	1.31M	N/A	1989
Mr. Schond L. Greenway M.B.A.	Chief Financial Officer	470.64k	N/A	1972
Dr. Daniel Rollings Karlin M.A., M.D.	Chief Medical Officer	909.83k	N/A	1981
Dr. Miriam Halperin Wernli Ph.D.	Executive President	757.42k	N/A	1953
Dr. Scott M. Freeman M.D.	Co-Founder & Clinical Advisor	430k	N/A	1957
Mr. Leonard Latchman	Co-founder	N/A	N/A	N/A
Ms. Carrie F. Liao CPA, CGMA	VP & Chief Accounting Officer	N/A	N/A	N/A
Mr. Mark R. Sullivan J.D.	Chief Legal Officer & Corporate Secretary	N/A	N/A	1971
Dr. Francois P. Lilienthal M.B.A., M.D.	Chief Commercial Officer	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Corporate Governance

Mind Medicine (MindMed) Inc.’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 7; Board: 5; Shareholder Rights: 3; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.